Skip to content

Heart Exercise And Remote Technologies Trial

A randomised controlled trial to determine the efficacy of an mobile (m)-health delivered exercise-based cardiac rehabilitation programme to increase exercise capacity and physical activity compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000117910
Acronym
HEART
Enrollment
170
Registered
2011-02-02
Start date
2011-04-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Exercise is the cornerstone of cardiac rehabilitation for people with heart disease. However many of those with heart disease do not undertake sufficient levels of exercise, and therefore do not realise the benefits, such as increased cardiovascular fitness, decreased weight and improved lipid profile. The proposed study aims to improve existing exercise based cardiac rehabilitation provision using a (m)-health delivery approach. One hundred and seventy participants will be allocated at random to receive a package of exercise prescription and behavioural support strategies via mobile phone and internet (m-health) for 6 months or usual care (advice to be physically active and encouragement to join a cardiac club). Assessments at baseline and 6-months will compare physical fitness, exercise levels, and quality of life in the different groups. If effective, this approach has enormous potential to improve the delivery of cardiac rehabilitation and could be scaled up nationally and internationally.

Interventions

The intervention is a m-health cardiac rehabilitation programme. Participants will receive a personalised automated package of text message components via their mobile phones to increase exercise behaviour delivered over 24 weeks. A total of 162 messages will be sent over 24 weeks. Participants will receive 1-2 messages per day for the first 6-weeks, then 8 messages per week from weeks 7-12 and then 4 messages per week from weeks 13-24. Participants will also have access to an interactive webs

The intervention is a m-health cardiac rehabilitation programme. Participants will receive a personalised automated package of text message components via their mobile phones to increase exercise behaviour delivered over 24 weeks. A total of 162 messages will be sent over 24 weeks. Participants will receive 1-2 messages per day for the first 6-weeks, then 8 messages per week from weeks 7-12 and then 4 messages per week from weeks 13-24. Participants will also have access to an interactive website which they may enter using a unique password and login. The website will be able to used at the participant's discretion and will contain messages sent to their phones which they can retrieve on demand, motivational messages, role model video clips, and weekly health and exercise tips.

Sponsors

Ralph Maddison
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. A clinically documented diagnosis of ischaemic heart disease (angina, myocardial infarction, revascularisation, including angioplasty, stent or coronary artery bypass graft) within the previous three to twelve months; 2. A current outpatient and is clinically stable 3. Able to perform exercise; 4. Able to understand and write English; 5. Own a mobile phone and have access to the internet.

Exclusion criteria

1. Have been admitted to hospital with heart disease within the previous 6 weeks; 2. Have terminal cancer; 3. Have significant exercise limitations other than CVD, or currently meet the recommendations for regular physical activity (150 min/week moderate intensity activity).

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 29, 2026